NPs Basic Information

Name
alpha-PINENE
Molecular Formula C10H16
IUPAC Name*
2,6,6-trimethylbicyclo[3.1.1]hept-2-ene
SMILES
CC1=CCC2CC1C2(C)C
InChI
InChI=1S/C10H16/c1-7-4-5-8-6-9(7)10(8,2)3/h4,8-9H,5-6H2,1-3H3
InChIKey
GRWFGVWFFZKLTI-UHFFFAOYSA-N
Synonyms
ALPHA-PINENE; 80-56-8; 2-Pinene; Acintene A; .alpha.-Pinene; 2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene; pin-2(3)-ene; Sylvapine A; (+/-)-2-Pinene; Pinene isomer; (+/-)-alpha-Pinene; 4,6,6-trimethylbicyclo[3.1.1]hept-3-ene; Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-; PINENE, ALPHA; alfa-Pinene; CHEBI:36740; NSC-7727; NSC94522; NSC94523; NCGC00090682-01; NSC 7727; DSSTox_CID_6501; DSSTox_RID_78126; DSSTox_GSID_26501; 2,6,6-Trimethylbicyclo(3.1.1)-2-hept-2-ene; 1S-.alpha.-Pinene; Leavo-95; CAS-80-56-8; DL-ALPHA-PINENE; 4,6,6-Trimethylbicyklo(3,1,1)hept-3-en; (1S)-(-)-alpha-Pinene; PC-500(TERPENE); alphapinene; alpha pinene; an alpha-pinene; Cyclic dexadiene; alpha -pinene; alpha.-pinene; PC-500; Acitene A; Alpha Pinene PF; (-)alpha-pinene; Pinene, .alpha.; pin-2-ene; alpha [D] Pinene; alpha [L] Pinene; (+-)-alpha-pinene; 1R-.alpha.-Pinene; 2,6,6-trimethyl-bicyclo[3.1.1]hept-2-ene; (R)-.alpha.-Pinene; (+-)-2-pinene; (-)-?-Pinene; (1R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene; (1S)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene; PINENE, ALPHA (D); PINENE, ALPHA (L); (.+/-.)-.alpha.-Pinene; CHEMBL442565; DTXSID4026501; NSC7727; alpha-Pinene (+/-)-alpha-Pinene; AMY22338; Tox21_110996; Tox21_200108; Tox21_303385; MFCD00001339; NSC-94522; NSC-94523; PC 500; AKOS000121239; AB86235; AB86464; AB93066; DB15573; UN 2368; NCGC00090682-02; NCGC00257379-01; NCGC00257662-01; 25766-18-1; LS-13835; 2,6-Trimethylbicyclo[3.1.1]-2-heptene; DB-017892; 2,6,6-Trimethylbicyclo[3.1.1]-2-heptene; alpha-Pinene 1000 microg/mL in Isopropanol; Bicyclo[3.1.1]hept-2-ene,6,6-trimethyl-; FT-0604379; FT-0604414; FT-0622197; FT-0698080; 2,6-Trimethylbicyclo[3.1.1]-2-hept-2-ene; EN300-21685; 2,6,6-Trimethyl bicyclo-(3,1,1)-2 heptene; C09880; A839247; Q-201582; (3Z)-5-METHYL-1H-INDOLE-2,3-DIONE3-OXIME; Q27104380; Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, (.+/-.)-; (+/-)-2-Pinene, 2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, alpha-Pinene
CAS 80-56-8
PubChem CID 6654
ChEMBL ID CHEMBL442565
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Monoterpenoids
          • Direct Parent: Bicyclic monoterpenoids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 136.23 ALogp: 2.8
HBD: 0 HBA: 0
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 0.0 Aromatic Rings: 3
Heavy Atoms: 10 QED Weighted: 0.444

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.303 MDCK Permeability: 0.00001830
Pgp-inhibitor: 0 Pgp-substrate: 0
Human Intestinal Absorption (HIA): 0.004 20% Bioavailability (F20%): 0.102
30% Bioavailability (F30%): 0.102

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.896 Plasma Protein Binding (PPB): 86.34%
Volume Distribution (VD): 1.73 Fu: 12.59%

ADMET: Metabolism

CYP1A2-inhibitor: 0.469 CYP1A2-substrate: 0.368
CYP2C19-inhibitor: 0.267 CYP2C19-substrate: 0.867
CYP2C9-inhibitor: 0.312 CYP2C9-substrate: 0.846
CYP2D6-inhibitor: 0.012 CYP2D6-substrate: 0.786
CYP3A4-inhibitor: 0.045 CYP3A4-substrate: 0.263

ADMET: Excretion

Clearance (CL): 15.022 Half-life (T1/2): 0.114

ADMET: Toxicity

hERG Blockers: 0.006 Human Hepatotoxicity (H-HT): 0.196
Drug-inuced Liver Injury (DILI): 0.023 AMES Toxicity: 0.002
Rat Oral Acute Toxicity: 0.021 Maximum Recommended Daily Dose: 0.42
Skin Sensitization: 0.158 Carcinogencity: 0.056
Eye Corrosion: 0.955 Eye Irritation: 0.985
Respiratory Toxicity: 0.825
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001827 0.478 D0V8HA 0.255
ENC000830 0.478 D0H1QY 0.244
ENC000770 0.478 D0A2AJ 0.203
ENC001898 0.436 D05VQI 0.188
ENC000613 0.421 D0K7LU 0.188
ENC000574 0.421 D0B4RU 0.182
ENC000482 0.421 D0K0EK 0.178
ENC002084 0.400 D0G6AB 0.171
ENC001831 0.360 D0P1FO 0.167
ENC000520 0.350 D04CSZ 0.167
*Note: the compound similarity was calculated by RDKIT.